Medicinal Cannabis: Issues of Evidence

ConclusionWe need to bring back the human element when considering what evidence we use and how we use it in medicine. Cannabis has the potential to alleviate much suffering, and patient (human) rights must be central in public policy. There is already much scientific evidence in relation to safety and efficacy of cannabis and cannabinoids such as CBD and THC. In Australia, the current regulatory system needs to be disbanded, cannabis products treated as ‘approved goods’ and regulated as complementary medicines (for products containing CBD and low THC) or in the case of high THC-containing products, regulated under the SUSMP as an S4 (rather than S8) medicine.
Source: European Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research